Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Ahmed S. Barefah"'
Autor:
Fatemah S. Basingab, Reem A. Alzahrani, Aisha A. Alrofaidi, Ahmed S. Barefah, Rawan M. Hammad, Hadil M. Alahdal, Jehan S. Alrahimi, Kawther A. Zaher, Ali H. Algiraigri, Mai M. El-Daly, Saleh A. Alkarim, Alia M. Aldahlawi
Publikováno v:
Biomolecules, Vol 14, Iss 5, p 523 (2024)
Herpesvirus entry mediator (HVEM) is a molecular switch that can modulate immune responses against cancer. The significance of HVEM as an immune checkpoint target and a potential prognostic biomarker in malignancies is still controversial. This study
Externí odkaz:
https://doaj.org/article/559e2bc2102942889e110d4e0060db11
Autor:
Eman M. Mansory, Hatem M. Alahwal, Salem M. Bahashwan, Osman Radhwi, Abdullah T. Almohammadi, Yassir Daghistani, Jamil Al-Mughales, Ahmed S. Barefah
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 1, p 243 (2023)
Background: Antiphospholipid antibodies (aPLs) are antibodies directed against cell membrane components and can be associated with clinical features or be asymptomatic. Testing and interpreting these antibodies is associated with many challenges and
Externí odkaz:
https://doaj.org/article/ffc4746b57264bf094640fca7c36baf5
Autor:
Mohammed S. Ziyadah, Eman M. Mansory, Hatem M. Alahwal, Salem M. Bahashwan, Abdullah T. Almohammadi, Osman O. Radhwi, Talal Alghamdi, Shahida A. Khan, Majed N. Almashjary, Ahmed S. Barefah
Publikováno v:
Journal of Clinical Medicine, Vol 12, Iss 20, p 6498 (2023)
Though patients with sickle cell disease (SCD) are at risk of developing venous thromboembolism (VTE), clear estimates of its incidence and predisposing factors in hospitalized SCD patients are not available. Therefore, this issue was addressed to fa
Externí odkaz:
https://doaj.org/article/e048aee181354587af56fc4a9878e8a7
Autor:
Arwa A. Faizo, Asma A. Bawazir, Majed N. Almashjary, Ahmed M. Hassan, Fadi S. Qashqari, Ahmed S. Barefah, Sherif A. El-Kafrawy, Thamir A. Alandijany, Esam I. Azhar
Publikováno v:
Vaccines, Vol 11, Iss 2, p 327 (2023)
Iron is a crucial micronutrient for immunity induction in response to infections and vaccinations. This study aimed to investigate the effect of iron deficiency on COVID-19-vaccine-induced humoral immunity. We investigated the effectiveness of COVID-
Externí odkaz:
https://doaj.org/article/5b52f660e90b46ab8fad96ed683c8b40
Autor:
Majed N. Almashjary, Ahmed S. Barefah, Salem Bahashwan, Ibraheem Ashankyty, Refaat ElFayoumi, Majed Alzahrani, Duaa M. Assaqaf, Raghad S. Aljabri, Amera Y. Aljohani, Rema Muslim, Sara A. Baawad, Waleed M. Bawazir, Saif A. Alharthy
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 19, p 5675 (2022)
Background: Iron deficiency anemia (IDA) is a global health problem affecting the quality of life of more than 2 billion individuals. The current practice guidelines diagnose and monitor IDA via conventional hematological and iron biomarkers, which t
Externí odkaz:
https://doaj.org/article/918fae35a3ed461c83f1439c2fcf8d2d
Autor:
Osman O. Radhwi, Hamza Jan, Abdullah Waheeb, Sawsan S. Alamri, Hatem M. Alahwal, Iuliana Denetiu, Ashgan Almanzlawey, Adel F. Al-Marzouki, Abdullah T. Almohammadi, Salem M. Bahashwan, Ahmed S. Barefah, Mohamad H. Qari, Adel M. Abuzenadah, Anwar M. Hashem
Publikováno v:
Vaccines, Vol 10, Iss 2, p 151 (2022)
Introduction: Studies assessing immune responses following Pfizer-BioNTech BNT162b2 mRNA COVID-19 (Pfizer) and ChAdOx1 nCoV-19 AZD1222 (AstraZeneca) vaccines in patients with hemoglobinopathy are non-existent in the literature despite being thought a
Externí odkaz:
https://doaj.org/article/d73585190acc45b9bb1e99d47f6f78cf
Autor:
Rakan H Alelyani, Ali H Alghamdi, Thamer A Almughamisi, Abdulrahman M Alshareef, Abdulaziz N Kadasa, Amir M Alrajhi, Abdullah K Alburayk, Ahmed S Barefah, Osman O Radhwi, Abdullah T Almohammadi, Salem M Bahashawan, Hatem M AlAhwal
Publikováno v:
Cureus.
Autor:
Sami H. Alzahrani, Mohamad H. Qari, Osman O. Radhwi, Hatem M. Alahwal, Walleed H. Nasraldeen, Ahmed S. Barefah, Salem Bahashwan, Anwar M. Hashem, Edrous Alamer, Adel M. Abuzenadah, Abdulaziz Alhazmi, Abdullah T. Almohammadi, Iuliana Denetiu, Abdullah Algaissi, Sawsan S. Al-amri
Publikováno v:
International Journal of Laboratory Hematology. 44:424-429
INTRODUCTION The development of anti-platelet factor 4 (PF4) antibodies is linked to a rare thrombotic complication described now as vaccine-induced immune thrombotic thrombocytopenia (VITT). This clinical syndrome with thrombosis and thrombocytopeni
Autor:
Asma S. A Alshamarni, Galila F. Zaher, Hatem M. Alahwal, Hanadi S. Almutiry, Haneen Banjar, Salwa A. Alnajjar, Ahmed S. Barefah, Salem Bahashwan, Ghaidaa Ibraheem Almouhana, Hajar Alharbi
Publikováno v:
Health informatics journal. 27(1)
β-thalassemia is an inherited blood disorder in which the body cannot produce hemoglobin normally. Since patients with this condition receive blood transfusions regularly, iron builds up primarily in organs such as the heart, liver and endocrine gla
Publikováno v:
Gynecologic Oncology Reports
Highlights • Tumour lysis syndrome is an oncologic emergency. • Tumour lysis syndrome is most commonly encountered in hematologic malignancies. • Herein we report a case of tumour lysis syndrome in an endometrial stromal sarcoma.